US4473639A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Reagent strip test for antithrombin-III
Assignee: Bayer Corp
•
Filing: 1982-09-15
•
Granted: 1984-09-25
•
Expires: 2002-09-15
Abstract
Abstract Disclosed is a method and device for the quantitative determination of AT-III in mammalian blood plasma. The method involves contacting a plasma sample containing excess heparin with a 3 layered reagent strip comprising: i. a first upper layer of a bibulous material containing thrombin and a buffer; ii. a second lower layer of a bibulous material containing a fluorogenic or chromogenic substrate capable of interacting with thrombin in a time related chemical manner; and iii. a bottom layer of water impermeable material. The chemical change in the strip is determined as a function of time and this change is compared with that obtained in samples containing known amounts of AT-III.
Inventors
- 👤 Ronald G. Sommer
- 👤 Alfred C. Greenquist
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 22:18
CPC Classifications
G; G03; G03F; G03F7/00; G03F7/70; G03F7/70216; C; C12; C12Q; C12Q1/00; C12Q1/56; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/52; G01N33/525; G01N33/526; G01N2333/00; G01N2333/81; G01N2333/8107; G01N2333/811; G01N2333/8121; G01N2333/8128; G01N2400/00; G01N2400/10; G01N2400/38; G01N2400/40; Y; Y10; Y10S; Y10S435/00; Y10S435/805
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
277 words
A method for the quantitative determination of AT-III in mammalian blood plasma which comprises: (a) contacting the plasma with excess heparin and a 3 layered reagent strip comprising: i. a first layer of a carrier matrix containing excess thrombin and a buffer; ii. a second lower layer adjacent to and in liquid communication with the first layer said second layer comprising a carrier matrix containing a thrombin sensitive fluorogenic or chromogenic substrate and a buffer, said substrate being capable of interacting with thrombin in such a manner that a time related chemical change detectable by fluorometric or spectrophotometric means takes place when thrombin and the substrate are contacted in a suitable liquid environment, wherein the material of the first layer is capable of adsorbing the plasma and allowing a portion of it to flow through into the lower layer which lower layer is of a material which allows the plasma fluid to solubilize the substrate and permits it to diffuse from the lower layer to the first layer after the AT-III in the plasma and the thrombin in the first layer have formed a thrombin AT-III complex; and iii. a layer of water impermeable material beneath the lower layer; (b) monitoring any chemical change in the substrate by reflectance spectrofluorometric or reflectance spectrophotometric means repeatedly over a period of time to obtain at least 2 fluorometric or spectrophotometric values as a function of time; and (c) comparing the relationship between the values obtained in step (b) with values obtained in a like manner using plasma samples containing known amounts of antithrombin-III and using such comparison to determine the concentration of antithrombin-III in the plasma sample being tested.
Claim 2
Independent Claim
277 words
A method for the quantitative determination of AT-III in mammalian blood plasma which comprises: (a) contacting the plasma with excess heparin and a 3 layered reagent strip comprising: i. a first layer of a carrier matrix containing excess thrombin and a buffer; ii. a second lower layer adjacent to and in liquid communication with the first layer said second layer comprising a carrier matrix containing a thrombin sensitive fluorogenic or chromogenic substrate and a buffer, said substrate being capable of interacting with thrombin in such a manner that a time related chemical change detectable by fluorometric or spectrophotometric means takes place when thrombin and the substrate are contacted in a suitable liquid environment, wherein the material of the first layer is capable of adsorbing the plasma and allowing a portion of it to flow through into the lower layer which lower layer is of a material which allows the plasma fluid to solubilize the substrate and permits it to diffuse from the lower layer to the first layer after the AT-III in the plasma and the thrombin in the first layer have formed a thrombin AT-III complex; and iii. a layer of water impermeable material beneath the lower layer; (b) monitoring any chemical change in the substrate by reflectance spectrofluorometric or reflectance spectrophotometric means repeatedly over a period of time to obtain at least 2 fluorometric or spectrophotometric values as a function of time; and (c) comparing the relationship between the values obtained in step (b) with values obtained in a like manner using plasma samples containing known amounts of antithrombin-III and using such comparison to determine the concentration of antithrombin-III in the plasma sample being tested.
Claim 3
Dependent Claim
16 words
The method of claim 1 wherein the first and second layers are made of filter paper.
Claim 4
Dependent Claim
15 words
The method of claim 1 wherein the thrombin sensitive material is the chromogenic substrate H-D-phe-pip-arg-pNA.
Claim 5
Dependent Claim
18 words
The method of claim 3 wherein the buffer is capable of maintaining a pH of 8.0 to 8.5.
Claim 6
Dependent Claim
15 words
The method of claim 1 wherein the thrombin sensitive material is the fluorogenic substrate D-phe-pro-arg-AIE.
Claim 7
Dependent Claim
193 words
A test device suitable for the quantitative determination of AT-III in mammalian blood plasma which comprises: i. a first upper layer of a carrier matrix containing excess thrombin and a buffer; ii. a second layer adjacent to and in liquid communication with the first layer said second layer comprising a carrier matrix containing a thrombin sensitive fluorogenic or chromogenic substrate and a buffer said substrate being capable of interacting with thrombin in such a manner that a time related chemical change detectable by fluorometric or spectromphotometric means takes place when thrombin and the substrate are contacted in a suitable liquid environment, said device being further defined in that the material of the first layer is capable of absorbing the plasma and allowing a portion of it to flow through into the second layer which second layer is of a material which allows the plasma fluid to solubilize the substrate and permits it to diffuse from the second layer to the first layer after the AT-III in the plasma and the thrombin in the first layer have formed a thrombin-At-III complex; and iii. a third layer of water impermeable material beneath the second layer.
Claim 8
Dependent Claim
193 words
A test device suitable for the quantitative determination of AT-III in mammalian blood plasma which comprises: i. a first upper layer of a carrier matrix containing excess thrombin and a buffer; ii. a second layer adjacent to and in liquid communication with the first layer said second layer comprising a carrier matrix containing a thrombin sensitive fluorogenic or chromogenic substrate and a buffer said substrate being capable of interacting with thrombin in such a manner that a time related chemical change detectable by fluorometric or spectromphotometric means takes place when thrombin and the substrate are contacted in a suitable liquid environment, said device being further defined in that the material of the first layer is capable of absorbing the plasma and allowing a portion of it to flow through into the second layer which second layer is of a material which allows the plasma fluid to solubilize the substrate and permits it to diffuse from the second layer to the first layer after the AT-III in the plasma and the thrombin in the first layer have formed a thrombin-At-III complex; and iii. a third layer of water impermeable material beneath the second layer.
Claim 9
Dependent Claim
16 words
The device of claim 6 wherein the first and second layers are made of filter paper.
Claim 10
Dependent Claim
15 words
The device of claim 6 wherein the thrombin sensitive material is the chromogenic substrate H-D-phe-pip-arg-pNA
Claim 11
Dependent Claim
18 words
The device of claim 8 wherein the buffer is capable of maintaining a pH of 8.0 to 8.5.
Claim 12
Dependent Claim
15 words
The device of claim 6 wherein the thrombin sensitive material is the fluorogenic substrate D-phe-pro-arg-AIE.
References Cited (Backward Citations)
US4061625A
Cited
US4234682A
Cited
US4275153A
Cited
US4221706A
Cited
US4324858A
Cited
US4390343A
Cited
US4363874A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-09-25 | 1988-03-26 | 1988-09-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-09-25 | 1992-03-26 | 1992-09-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-09-25 | 1996-03-26 | 1996-09-25 | $7700.00 | Window Closed / Lapsed |